Clinical Trials
-
{
- All
- News
- Videos
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Copper Therapy Reduces Toxic Brain Proteins, Says Study: What Exactly Is It?
A new study highlights that copper therapy can reduce toxic brain proteins. Here is how this can happen and why the level of copper in your body influences brain health.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Universal Artificial Blood For All Types In Clinical Trials, Could Save Millions
Unlike donated blood, these artificial cells have no blood type, eliminating the need for any compatibility, making them invaluable in emergencies.
-
New HIV Pill Delivers Breakthrough Results In First Human Trial
Researchers say the treatment appears safe and effective so far, although larger Phase 3 trials will be needed before it can be approved for widespread use.
-
Copper Therapy Reduces Toxic Brain Proteins, Says Study: What Exactly Is It?
A new study highlights that copper therapy can reduce toxic brain proteins. Here is how this can happen and why the level of copper in your body influences brain health.
-
Highly Effective Prevention Drug Arrives In South Africa, Which Has World's Highest HIV Burden
South Africa launches lenacapavir, a twice-yearly injectable HIV prevention drug, aiming to reduce new infections in the country with the highest HIV burden globally.
-
WHO Urges Ebola Treatments, Vaccines Be Tested Only In Trials Amid Bundibugyo Outbreak
The World Health Organization said that experimental treatments and vaccines for Ebola caused by the Bundibugyo virus should only be used in clinical trials, as it works with affected countries to assess their safety and effectiveness.
-
Bad Cholesterol Reduction: Single Gene Therapy Dose Shows 62% Drop
A one-time gene therapy for treating hypercholesterolaemia could lower up to 62 per cent 'bad' cholesterol in the blood, with reductions sustaining over time, according to results of a clinical trial published in The New England Journal of Medicine.
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
ICMR Hosts First Annual Clinical Trial Meet To Boost Integrative Medicine Research
The Indian Council of Medical Research (ICMR)'s multicentric Phase III clinical trial has found that Ayurvedic formulations are therapeutically equivalent to standard iron-folic acid supplementation in treating moderate iron deficiency anaemia among
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Rare Epilepsy Breakthrough: Why This New Treatment Is Reducing Seizure Frequency In Children By 91%
An international clinical trial has achieved a new effective treatment option for rare epilepsy that can reduce seizures by 91% in children. Here is what this breakthrough means for the children suffering from Dravet Syndrome.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Medical Trials To Now Focus On Indian Body Type, Data: New ICMR Mandate
The Indian Council of Medical Research has implemented a new mandate that prioritises clinical trials based on Indian body types and lifestyles for greater accuracy. Here is what you should know and why it matters.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
Nipah Breakthrough: Japan To Begin First Human Vaccine Trial In April
A team of researchers in Japan has announced a clinical trial to confirm a vaccine's efficacy against the deadly Nipah virus in humans.
-
This New Weight Loss Drug Beats All Current Treatments In New Clinical Trial
A new drug, ecnoglutide, may outperform current weight-loss treatments like Ozempic by targeting a specific metabolic pathway, showing strong results in recent trials.
-
Universal Artificial Blood For All Types In Clinical Trials, Could Save Millions
Unlike donated blood, these artificial cells have no blood type, eliminating the need for any compatibility, making them invaluable in emergencies.
